Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Ann Surg Oncol. 2015 Feb 7;22(11):3613–3617. doi: 10.1245/s10434-015-4415-5

Table 2. Use of adjuvant systemic and/or intraperitoneal chemotherapy.

Adenocarcinoma n (%) Goblet cell carcinoid n (%)
n (%) 18/32 (56) 17/38 (45)
Stage 1 0/3 (0) 0/3 (0)
Stage 2 10/20 (50) 13/30 (43)
Stage 3 8/9 (89) 4/5 (80)